Projects funded by the NCN
A triple agonist of glucagon, GLP-1, and GIP receptors as a novel therapeutic option for the treatment of heart failure with preserved ejection fraction. Effects on diastolic dysfunction, arrhythmogenesis, and quality of life.
2024/55/D/NZ5/02787
Keywords:
Heart failure with preserved ejection fraction diastolic heart failure SGLT2 GLP-1 GIP glucagon retatrutide dapagliflozin
Descriptors:
- NZ5_03:
- NZ5_07:
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Centrum Medyczne Kształcenia Podyplomowego
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 4
Call: SONATA 20 - announced on 2024-09-16
Amount awarded: 1 299 540 PLN
Project start date (Y-m-d): 2025-07-25
Project end date (Y-m-d): 2028-07-24
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.